We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Apologies my error - full steam ahead for saliva then, let’s hope they can nail it.
Genedrive has already completed initial evaluation of Beckman Coulter's RNA extraction chemistry to confirm compatibility with the Genedrive 96 SARS-CoV-2 test. Further work is ongoing to validate clinical saliva samples which are a very relevant sample type for applications such as high volume occupational screening. Beckman's RNAdvance Viral XP has already been listed as an extraction method for swab samples for use with the Centers for Disease Control's EUA-authorized COVID-19 test in FDA's FAQ on testing for SARS-CoV-2.
Plant, it’s Saliva not Swab.
This is confirmed with GDR.
Plant, the 4th August RNS says it’s saliva I think
Key question - will BC validation be swab 1st / saliva 2nd, or .......do not pass go, do not collect £100 & move straight to Park Lane & saliva validation....!?!?
PP
In the USA you don’t need an approval to sell to a lab. Confirmed.
@Bench could not agree more about the state of play. Just need the approvals so we can all make some money :)
@Technik hadn't thought of it that way. just need the approvals so we can all make some money :)
@ihavenoclue ...........I think your right :)
Grim, sounds like approvals are the only thing that will out your mind at rest TBH.
For me if Beckman like what they see we are sorted. They can pushed through FDA approval which then sorts India but the way I think it will roll out in the US that in itself is mind blowing from our current market cap IMHO
To hell with test run and FOC. They are useless. They can see GDRs product and the fact it doesn't need a lab and then give us a slice on the initial tender. Then give us follow on orders when the product gets them out the soft and smelly.
Grim, one ray of light is that the lab approval would probably have been run along the lines that the lab was competent to run their diagnostic testing for COVID, they would of checked procedures, quality control and process. The fact is this would have been centred around the Genedrive test, so they would all be pretty confident everything would align. It’s not there until it’s there, but it’s all but there.
if I am in charge of GDR I would as bold as telling the government that let us do a test run FOC if they are not with the speed and accuracy of our test!! and would only have to pay if they are totally satisfied how efficient and fast GDR can and will be.
I know Grim ...but my take on it is with all the testing requirements both here in the UK and around the world which will need to be conducted in ever more efficient format to keep up with demand it plays out perfectly for GDR's technology.. As Technick I think it was said the other day, the lab technicians are being run ragged with the manually operated systems and that's why the testing centres are closing due to the bottle neck at Labs... Automation is the only way forwards and in the less developed and warmer countries where even a basic lab is hard to find locally, the current systems are just not sustainable.. GDR's POC will literally take hundreds of man hours out of the equation... Next few months will be company changing IMHO.
really hope so Bench :)
There have been so many false dawns with Genedrive over the years, its hard sometimes to believe we might be on the cusp of achieving the potential. Maybe i looking for issues that aren't there.
Spot on Technick.
Grim my bet is its all being lined up perfectly over in India... Divoc would be shouting from the rooftops if we were not right behind them in terms of Regulatory approval.... I fully understand the caution aspect and it's wise to have that approach when trading on the AIM but I honestly think here it's as good as done. ...just my view.
i hate to be a voice of caution here but with out the approvals (which i am sure we will get just when) we can have as many potential customers as we like but it makes no difference. what happens if we don't get either approval this week and Divoc have 500k orders for tests? Are they going to tell customers no wait a week or maybe two till we can use the test we wish to? Of course there not they are going to go else where. once they have made that initial order how long till they need restocking? will we get the contract off who ever gets that initial order? ( you can bet your bottom dollar they will fight tooth and nail to keep it). With Beckman maybe a slightly different story as they can't do the number of tests they promised with out GDR (or that is how i read it)
God i sound like a moaning tw at so someone put my mind at rest please.
What we need to recognise is that DIVOC are also doing the testing so unlike the other distributors GDR have that then find customers, DIVOC are the customer. Amazing opportunity and a great partnership.
To some extent BC is the same as they’re providing a closed systems to customers that from the sound of the RNS are already in place.
Once approvals are in, sales are staked up and market cap will soar.